CIC
Canal Insurance Company Portfolio holdings
AUM
$447M
This Quarter Return
+5.65%
1 Year Return
+31.74%
3 Year Return
+51.19%
5 Year Return
+114.65%
10 Year Return
+227.18%
AUM
$283M
AUM Growth
+$283M
(+8.5%)
Cap. Flow
+$16M
Cap. Flow
% of AUM
5.65%
Top 10 Holdings %
Top 10 Hldgs %
46.39%
Holding
64
New
11
Increased
7
Reduced
6
Closed
–
Top Buys
| 1 |
Canadian Pacific Kansas City
CP
|
$6.16M |
| 2 |
GSK
GSK
|
$3.98M |
| 3 |
AeroVironment
AVAV
|
$2.9M |
| 4 |
B
Barrick Mining Corporation
B
|
$2.49M |
| 5 |
BP
BP
|
$2.11M |
Top Sells
| 1 |
RTX Corp
RTX
|
$4.27M |
| 2 |
CVS Health
CVS
|
$4.17M |
| 3 |
Pfizer
PFE
|
$2.94M |
| 4 |
RDS.A
Royal Dutch Shell PLC ADS Class A
RDS.A
|
$808K |
| 5 |
Microsoft
MSFT
|
$677K |
Sector Composition
| 1 | Healthcare | 29.99% |
| 2 | Industrials | 23.66% |
| 3 | Technology | 13.4% |
| 4 | Energy | 12.72% |
| 5 | Utilities | 6.56% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
1
Microsoft
MSFT
$3.77T
| $20.2M | 7.1% | 74,500 -2,500 | -3% | -$677K |
|
2
Duke Energy
DUK
$95.3B
| $14.8M | 5.22% | 150,166 | – | – |
|
3
Northrop Grumman
NOC
$84.5B
| $14.6M | 5.13% | 40,093 | – | – |
|
4
Lockheed Martin
LMT
$106B
| $13.8M | 4.87% | 36,600 | – | – |
|
|
5
CVS Health
CVS
$92.8B
| $13.8M | 4.85% | 165,000 -50,000 | -23% | -$4.17M |
|
6
Johnson & Johnson
JNJ
$427B
| $12.4M | 4.35% | 75,000 | – | – |
|
7
IBM
IBM
$227B
| $11.9M | 4.18% | 81,000 | – | – |
|
8
AbbVie
ABBV
$372B
| $11.8M | 4.16% | 105,000 | – | – |
|
9
Chevron
CVX
$324B
| $9.35M | 3.29% | 89,240 | – | – |
|
|
10
RTX Corp
RTX
$212B
| $8.84M | 3.11% | 103,662 -50,000 | -33% | -$4.27M |
|
11
Bristol-Myers Squibb
BMY
$96B
| $8.02M | 2.82% | 120,000 | – | – |
|
12
Merck
MRK
$210B
| $7.78M | 2.74% | 100,000 | – | – |
|
|
13
Canadian Pacific Kansas City
CP
$69.9B
| $7.7M | 2.71% | 100,000 +80,000 | +400% | +$6.16M |
|
14
Exxon Mobil
XOM
$487B
| $6.62M | 2.33% | 105,000 | – | – |
|
|
15
Pfizer
PFE
$141B
| $6.04M | 2.12% | 154,200 -75,000 | -33% | -$2.94M |
|
16
Abbott
ABT
$231B
| $5.8M | 2.04% | 50,000 +10,000 | +25% | +$1.16M |
|
17
Baxter International
BAX
$12.7B
| $5.64M | 1.98% | 70,000 | – | – |
|
18
iShares Short Maturity Bond ETF
NEAR
$3.52B
| $5.02M | 1.77% | 100,000 | – | – |
|
|
19
BP
BP
$90.8B
| $4.76M | 1.67% | 180,000 +80,000 | +80% | +$2.11M |
|
20
Becton Dickinson
BDX
$55.3B
| $4.65M | 1.64% | 19,123 | – | – |
|
21
Thermo Fisher Scientific
TMO
$186B
| $4.54M | 1.6% | 9,000 | – | – |
|
22
Newmont
NEM
$81.7B
| $4.44M | 1.56% | 70,000 | – | – |
|
23
Fluor
FLR
$6.63B
| $4.43M | 1.56% | 250,000 | – | – |
|
24
L3Harris
LHX
$51.9B
| $4.32M | 1.52% | 20,000 | – | – |
|
25
AT&T
T
$209B
| $4.03M | 1.42% | 140,000 | – | – |
|